VolitionRx Limited (VNRX) Financials
VNRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 9.0 million | 41.9 million |
| Dec. 31, 2025 | 6.9 million | 42.5 million |
| Sept. 30, 2025 | 6.4 million | 42.4 million |
| June 30, 2025 | 8.7 million | 41.8 million |
VNRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -5.3 million | 224981 |
| Dec. 31, 2025 | -5.5 million | -132875 |
| Sept. 30, 2025 | -3.5 million | 609167 |
| June 30, 2025 | -6.3 million | 812045 |
VNRX Net Income
No data available :(
VNRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 3.1 million | 6.6 million | 507044 |
| Dec. 31, 2025 | 1.1 million | 7.3 million | 899130 |
| Sept. 30, 2025 | 199407 | 7.8 million | 991425 |
| June 30, 2025 | 2.3 million | 8.7 million | 1.1 million |
VNRX Shares Outstanding
VNRX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 9214 | 2.9 million | 3.5 million | 851851 |
| Dec. 31, 2025 | 10967 | 2.5 million | 2.8 million | 233675 |
| Sept. 30, 2025 | 1178 | 2.3 million | 3.4 million | 213364 |
| June 30, 2025 | 76783 | 2.7 million | 3.9 million | 181175 |
VNRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 985076 | 254411 |
| Dec. 31, 2025 | 447034 | - |
| Sept. 30, 2025 | 627277 | - |
| June 30, 2025 | 406688 | - |
VNRX
Price: $2.08
52 week price:
Earnings Per Share: -4.40 USD
Exchange: ASE
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 202636
Market Capitalization: 19.0 million